Establishes the "End-Stage Kidney Disease Prevention and Innovation Act" to fund research and education on rare kidney disease.
The End-Stage Kidney Disease Prevention and Innovation Act establishes centers for rare kidney disease research and education. The Department of Health will award grants to public and private nonprofit entities to support these centers. The centers will conduct research on rare kidney diseases, develop resources for clinical research, and increase public awareness. The bill also mandates a study on testing, preventative care, precision medicine, and treatment for rare kidney disease. Funding for these initiatives is set at $10 million.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.